Alessandro Bonardi

2.0k total citations
90 papers, 1.6k citations indexed

About

Alessandro Bonardi is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Alessandro Bonardi has authored 90 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 65 papers in Organic Chemistry and 29 papers in Pharmacology. Recurrent topics in Alessandro Bonardi's work include Enzyme function and inhibition (83 papers), Synthesis and Catalytic Reactions (65 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (32 papers). Alessandro Bonardi is often cited by papers focused on Enzyme function and inhibition (83 papers), Synthesis and Catalytic Reactions (65 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (32 papers). Alessandro Bonardi collaborates with scholars based in Italy, Egypt and Saudi Arabia. Alessandro Bonardi's co-authors include Claudiu T. Supuran, Alessio Nocentini, Paola Gratteri, Wagdy M. Eldehna, Hatem A. Abdel‐Aziz, Silvia Bua, Andrea Angeli, Mahmoud F. Abo-Ashour, Hany S. Ibrahim and Sahar M. Abou‐Seri and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Alessandro Bonardi

85 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Bonardi Italy 24 1.3k 1.2k 404 231 86 90 1.6k
Silvia Bua Italy 33 2.4k 1.9× 2.2k 1.9× 846 2.1× 437 1.9× 138 1.6× 112 3.0k
Murat Bozdağ Italy 22 996 0.8× 842 0.7× 362 0.9× 206 0.9× 61 0.7× 48 1.2k
Hany S. Ibrahim Egypt 23 785 0.6× 1.0k 0.9× 170 0.4× 108 0.5× 153 1.8× 46 1.3k
Ghada S. Hassan Egypt 27 707 0.6× 1.4k 1.2× 191 0.5× 69 0.3× 128 1.5× 69 1.8k
Katia D’Ambrosio Italy 16 1.5k 1.2× 1.1k 0.9× 532 1.3× 395 1.7× 48 0.6× 22 1.6k
Mahmoud F. Abo-Ashour Egypt 18 675 0.5× 832 0.7× 183 0.5× 99 0.4× 106 1.2× 22 1.0k
Asta Zubrienė Lithuania 20 740 0.6× 392 0.3× 159 0.4× 314 1.4× 38 0.4× 62 922
Shikha Kumari India 21 598 0.5× 910 0.8× 303 0.8× 33 0.1× 78 0.9× 43 1.4k
Laurence Goossens France 19 579 0.5× 651 0.6× 206 0.5× 32 0.1× 127 1.5× 50 1.2k
Adriano Guiotto Italy 23 572 0.5× 865 0.7× 367 0.9× 29 0.1× 105 1.2× 59 1.5k

Countries citing papers authored by Alessandro Bonardi

Since Specialization
Citations

This map shows the geographic impact of Alessandro Bonardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Bonardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Bonardi more than expected).

Fields of papers citing papers by Alessandro Bonardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Bonardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Bonardi. The network helps show where Alessandro Bonardi may publish in the future.

Co-authorship network of co-authors of Alessandro Bonardi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Bonardi. A scholar is included among the top collaborators of Alessandro Bonardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Bonardi. Alessandro Bonardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonardi, Alessandro & Claudiu T. Supuran. (2025). Polypharmacology of carbonic anhydrase inhibitors and activators. Expert Opinion on Pharmacotherapy. 26(5). 567–580. 4 indexed citations
2.
Bonardi, Alessandro, Alessio Nocentini, Simone Giovannuzzi, et al.. (2024). Development of Penicillin-Based Carbonic Anhydrase Inhibitors Targeting Multidrug-Resistant Neisseria gonorrhoeae. Journal of Medicinal Chemistry. 67(11). 9613–9627. 7 indexed citations
3.
Abdoli, Morteza, Alessandro Bonardi, Claudiu T. Supuran, Claudiu T. Supuran, & Raivis Žalubovskis. (2024). Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines. ChemMedChem. 19(19). e202400197–e202400197. 3 indexed citations
4.
Bonardi, Alessandro & Paola Gratteri. (2024). Computational studies of tyrosinase inhibitors. ˜The œEnzymes. 56. 191–229. 1 indexed citations
5.
Giovannuzzi, Simone, Andrea Angeli, Michaël Smietana, et al.. (2024). Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity. Journal of Medicinal Chemistry. 67(20). 18221–18234. 5 indexed citations
6.
Eldehna, Wagdy M., Alessio Nocentini, Alessandro Bonardi, et al.. (2023). 4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments. European Journal of Medicinal Chemistry. 250. 115180–115180. 37 indexed citations
8.
Aspatwar, Ashok, Alessandro Bonardi, Craig R. Primmer, et al.. (2023). Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite Gyrodactylus salaris. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2167988–2167988. 4 indexed citations
9.
Bonardi, Alessandro, Sameena Bano, Kalicharan Sharma, et al.. (2023). Synthesis, biological evaluation and theoretical studies of ( E )-1-(4-sulfamoyl-phenylethyl)-3-arylidene-5-aryl-1H-pyrrol-2(3H)-ones as human carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2189126–2189126. 2 indexed citations
10.
Allam, Heba Abdelrasheed, Walaa R. Mahmoud, Alessandro Bonardi, et al.. (2023). Effect of hydrophobic extension of aryl enaminones and pyrazole-linked compounds combined with sulphonamide, sulfaguanidine, or carboxylic acid functionalities on carbonic anhydrase inhibitory potency and selectivity. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2201403–2201403. 6 indexed citations
11.
Bonardi, Alessandro, Alessio Nocentini, Paola Gratteri, et al.. (2023). Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies. Bioorganic & Medicinal Chemistry. 94. 117467–117467. 6 indexed citations
12.
Nocentini, Alessio, Alessandro Bonardi, Carla Bazzicalupi, et al.. (2023). 6-Substituted Triazolyl Benzoxaboroles as Selective Carbonic Anhydrase Inhibitors: In Silico Design, Synthesis, and X-ray Crystallography. Journal of Medicinal Chemistry. 66(12). 8118–8129. 13 indexed citations
13.
Bonardi, Alessandro, Laura Micheli, Lorenzo Di Cesare Mannelli, et al.. (2022). Development of Hydrogen Sulfide-Releasing Carbonic Anhydrases IX- and XII-Selective Inhibitors with Enhanced Antihyperalgesic Action in a Rat Model of Arthritis. Journal of Medicinal Chemistry. 65(19). 13143–13157. 19 indexed citations
14.
Nocentini, Alessio, Alessandro Bonardi, Simone Pratesi, et al.. (2022). Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 487–501. 29 indexed citations
15.
Bonardi, Alessandro, Silvia Bua, Andrea Angeli, et al.. (2021). Calixarenes Incorporating Sulfonamide Moieties: Versatile Ligands for Carbonic Anhydrases Inhibition. Chemistry - A European Journal. 28(6). e202103527–e202103527. 5 indexed citations
16.
Elgazar, Abdullah A., Alessandro Bonardi, Alessio Nocentini, et al.. (2021). Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry. 225. 113800–113800. 34 indexed citations
17.
Abdelrahman, Mohamed A., Hany S. Ibrahim, Alessio Nocentini, et al.. (2020). Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis. European Journal of Medicinal Chemistry. 209. 112897–112897. 55 indexed citations
18.
Abdelrahman, Mohamed A., Wagdy M. Eldehna, Alessio Nocentini, et al.. (2019). Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights. International Journal of Molecular Sciences. 20(10). 2484–2484. 21 indexed citations
19.
Said, Mohamed A., Wagdy M. Eldehna, Alessio Nocentini, et al.. (2019). Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry. 185. 111843–111843. 50 indexed citations
20.
Bonardi, Alessandro, Matteo Falsini, Daniela Catarzi, et al.. (2018). Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII. European Journal of Medicinal Chemistry. 146. 47–59. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026